Addition of Anti-Angiogenetic Therapy With Bevacizumab to Chemo- And Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors

PLoS ONE - United States
doi 10.1371/journal.pone.0155315
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Bevacizumab: Review of Development, Pharmacology, and Application to Brain Tumors

Clinical Medicine. Therapeutics
2009English

Focal Management of Large Brain Metastases and Risk of Leptomeningeal Disease

Advances in Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

Anti-Angiogenetic Therapies for Central Nervous System Metastases From Non-Small Cell Lung Cancer

Translational Lung Cancer Research
Oncology
2016English

Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing From Whole-Brain Radiotherapy

Clinical Cancer Research
Cancer ResearchOncology
2015English

Stereotactic Radiosurgery With or Without Whole Brain Radiotherapy for Patients With One to Three Melanoma Brain Metastases

Journal of Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2012English

Boost Irradiation Integrated to Whole Brain Radiotherapy in the Management of Brain Metastases

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2018English

Cauda Equina Syndrome Secondary to Leptomeningeal Metastases From Recurrent Primary Peritoneal Carcinoma

ecancermedicalscience
Cancer ResearchOncology
2018English

Long-Term Cognitive Dysfunction After Radiation Therapy for Primary Brain Tumors

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2019English

Prognosis of the Course and Systemic Therapy of Patients With Brain Metastases of Solid Tumors (Literature Review)

Practical oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy